System Transmission

Top Signal

100#1 JOB

Activity

2173Ripe

+914 today

System

Livenow

Terminal Asset View

stockNASDAQ

ABVX

$115.50-1.27%

Abivax

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

36Neutral

Live Analysis Active

Company Mission

Abivax researches and develops new medicines for serious long-term inflammatory diseases like ulcerative colitis. These are conditions where the body's immune system attacks its own tissues, causing pain and damage. The company makes money by partnering with larger pharmaceutical companies and hopes to earn revenue from selling approved drugs in the future.

ABV

Industry Context

The biotech industry focuses on developing new medical treatments through scientific research. Companies in this space often see significant price movements when they release clinical trial results or receive regulatory approvals, as these events can dramatically change their future prospects.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

60Matrix

Market Momentum

47.5— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

-1.27%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ABVX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 12:37 AM UTC

As-of 03-15-2026 00:22 UTC

Develops drugs that treat inflammatory diseases and makes money by selling these medicines to hospitals and pharmacies.

Price is compressing on the weekly chart near recent levels, suggesting potential volatility expansion soon showing consolidation pattern.

Biotech sector showing renewed interest as clinical trial data emerges, benefiting companies with promising late-stage candidates, suggesting.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...